Beam Therapeutics Inc. (BEAM) · Insider trading
What Beam Therapeutics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$19.75M
7 insiders, 49% under a plan
Net, 12 months
−$19.75M
bought less sold
Latest filing
2026-10-16
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Fmr LLC10% owner, Other | – | $11.04M | 4 | 2026-06-26 | – |
| Evans John M.Director, CEO | – | $8.84M | 18 | 2026-10-16 | 1,047,205 |
| Ciaramella GiuseppePresident | – | $2.89M | 4 | 2026-04-01 | 218,406 |
| Bellon ChristineChief Legal Officer | – | $1.36M | 10 | 2026-04-01 | 109,711 |
| Simon AmyChief Medical Officer | – | $1.18M | 7 | 2026-07-27 | 85,696 |
| Cavanagh Bethany JSVP, Finance and Treasurer | – | $706,960 | 8 | 2026-10-01 | 50,984 |
| Emany Sravan KumarChief Financial Officer | – | $170,567 | 1 | 2025-12-31 | 73,706 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Evans John M.Director, CEO | Saleplan | 25,000 | 23.98 | $599,595 | 1,047,205 | Form 4 |
| 2026-10-15 | Evans John M.Director, CEO | Saleplan | 25,000 | 23.57 | $589,150 | 1,047,205 | Form 4 |
| 2026-10-01 | Cavanagh Bethany JSVP, Finance and Treasurer | Saleplan | 187 | 24.41 | $4,565 | 50,984 | Form 4 |
| 2026-07-27 | Simon AmyChief Medical Officer | Saleplan | 16,667 | 25.74 | $429,009 | 85,696 | Form 4 |
| 2026-06-30 | Simon AmyChief Medical Officer | Saleplan | 373 | 34.73 | $12,954 | 102,363 | Form 4 |
| 2026-06-30 | Evans John M.Director, CEO | Saleplan | 23,100 | 34.26 | $791,406 | 1,049,105 | Form 4 |
| 2026-06-30 | Evans John M.Director, CEO | Saleplan | 1,900 | 34.84 | $66,196 | 1,047,205 | Form 4 |
| 2026-06-29 | Evans John M.Director, CEO | Saleplan | 13,421 | 35.13 | $471,480 | 1,058,784 | Form 4 |
| 2026-06-29 | Evans John M.Director, CEO | Saleplan | 11,579 | 35.91 | $415,802 | 1,047,205 | Form 4 |
| 2026-06-26 | Fmr LLC10% owner, Other | Saleindirect | 251,488 | 35.26 | $8.87M | 854,583 | Form 4 |
| 2026-06-25 | Fmr LLC10% owner, Other | Saleindirect | 33,372 | 35.12 | $1.17M | 1,106,071 | Form 4 |
| 2026-04-01 | Ciaramella GiuseppePresident | Saleplan | 11,810 | 24.58 | $290,290 | 218,406 | Form 4 |
| 2026-04-01 | Bellon ChristineChief Legal Officer | Saleplan | 5,956 | 24.58 | $146,398 | 109,711 | Form 4 |
| 2026-04-01 | Cavanagh Bethany JSVP, Finance and Treasurer | Saleplan | 3,242 | 24.58 | $79,688 | 51,171 | Form 4 |
| 2026-04-01 | Simon AmyChief Medical Officer | Saleplan | 6,700 | 24.58 | $164,686 | 102,735 | Form 4 |
| 2026-04-01 | Evans John M.Director, CEO | Saleplan | 30,078 | 24.58 | $739,317 | 1,047,205 | Form 4 |
| 2026-03-31 | Evans John M.Director, CEO | Saleplan | 25,000 | 22.76 | $569,000 | 986,667 | Form 4 |
| 2026-03-30 | Evans John M.Director, CEO | Saleplan | 25,000 | 22.37 | $559,250 | 986,667 | Form 4 |
| 2026-02-24 | Ciaramella GiuseppePresident | Saleplan | 35,000 | 32.00 | $1.12M | 190,216 | Form 4 |
| 2026-01-30 | Evans John M.Director, CEO | Saleplan | 22,094 | 28.27 | $624,597 | 989,573 | Form 4 |
| 2026-01-30 | Evans John M.Director, CEO | Saleplan | 2,906 | 29.00 | $84,274 | 986,667 | Form 4 |
| 2026-01-29 | Evans John M.Director, CEO | Saleplan | 16,333 | 29.19 | $476,760 | 995,334 | Form 4 |
| 2026-01-29 | Evans John M.Director, CEO | Saleplan | 8,667 | 29.74 | $257,757 | 986,667 | Form 4 |
| 2026-01-22 | Bellon ChristineChief Legal Officer | Saleplan | 1,371 | 34.00 | $46,614 | 95,667 | Form 4 |
| 2026-01-22 | Cavanagh Bethany JSVP, Finance and Treasurer | Saleplan | 6,198 | 35.00 | $216,930 | 34,813 | Form 4 |
| 2026-01-20 | Cavanagh Bethany JSVP, Finance and Treasurer | Saleplan | 3,034 | 30.12 | $91,384 | 41,011 | Form 4 |
| 2026-01-15 | Bellon ChristineChief Legal Officer | Saleplan | 2,111 | 33.62 | $70,972 | 113,556 | Form 4 |
| 2026-01-15 | Bellon ChristineChief Legal Officer | Saleplan | 15,959 | 34.72 | $554,096 | 97,597 | Form 4 |
| 2026-01-15 | Bellon ChristineChief Legal Officer | Saleplan | 559 | 35.40 | $19,789 | 97,038 | Form 4 |
| 2025-12-31 | Bellon ChristineChief Legal Officer | Saleplan | 1,254 | 27.10 | $33,983 | 115,667 | Form 4 |
| 2025-12-31 | Emany Sravan KumarChief Financial Officer | Saleplan | 6,294 | 27.10 | $170,567 | 73,706 | Form 4 |
| 2025-10-27 | Fmr LLC10% owner, Other | Saleindirect | 459 | 26.68 | $12,246 | 14 | Form 4 |
| 2025-10-02 | Evans John M.Director, CEO | Saleplan | 25,000 | 24.63 | $615,750 | 986,667 | Form 4 |
| 2025-10-01 | Evans John M.Director, CEO | Saleplan | 25,000 | 24.51 | $612,750 | 986,667 | Form 4 |
| 2025-10-01 | Bellon ChristineChief Legal Officer | Saleplan | 373 | 24.53 | $9,150 | 116,921 | Form 4 |
| 2025-10-01 | Cavanagh Bethany JSVP, Finance and Treasurer | Saleplan | 467 | 24.53 | $11,456 | 44,045 | Form 4 |
| 2025-07-30 | Fmr LLC10% owner, Other | Saleindirect | 48,374 | 20.50 | $991,667 | 2,073,665 | Form 4 |
| 2025-07-03 | Simon AmyChief Medical Officer | Saleplan | 876 | 20.12 | $17,625 | 64,864 | Form 4 |
| 2025-07-01 | Simon AmyChief Medical Officer | Saleplan | 374 | 16.94 | $6,336 | 65,740 | Form 4 |
| 2025-04-02 | Simon AmyChief Medical Officer | Saleplan | 20,997 | 17.73 | $372,277 | 65,742 | Form 4 |
12 more
| 2025-04-01 | Simon AmyChief Medical Officer | Saleplan | 9,566 | 18.35 | $175,536 | 86,739 | Form 4 |
| 2025-04-01 | Cavanagh Bethany JSVP, Finance and Treasurer | Saleplan | 3,015 | 18.35 | $55,325 | 44,512 | Form 4 |
| 2025-04-01 | Ciaramella GiuseppePresident | Saleplan | 7,434 | 18.35 | $136,414 | 190,216 | Form 4 |
| 2025-04-01 | Evans John M.Director, CEO | Saleplan | 30,663 | 18.35 | $562,666 | 986,249 | Form 4 |
| 2025-04-01 | Bellon ChristineChief Legal Officer | Saleplan | 5,674 | 18.35 | $104,118 | 117,294 | Form 4 |
| 2025-02-18 | Cavanagh Bethany JSVP, Finance and Treasurer | Saleplan | 6,287 | 35.00 | $220,045 | 37,527 | Form 4 |
| 2025-02-14 | Bellon ChristineChief Legal Officer | Saleplan | 10,000 | 34.00 | $340,000 | 102,968 | Form 4 |
| 2025-01-30 | Evans John M.Director, CEO | Saleplan | 29,800 | 26.75 | $797,150 | 908,859 | Form 4 |
| 2025-01-30 | Evans John M.Director, CEO | Saleplan | 200 | 27.28 | $5,456 | 908,659 | Form 4 |
| 2025-01-02 | Cavanagh Bethany JSVP, Finance and Treasurer | Saleplan | 1,117 | 24.68 | $27,568 | 43,814 | Form 4 |
| 2025-01-02 | Bellon ChristineChief Legal Officer | Saleplan | 1,241 | 24.68 | $30,628 | 102,968 | Form 4 |
| 2024-11-06 | Ciaramella GiuseppePresident | Saleplan | 51,110 | 26.36 | $1.35M | 109,150 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
19 × option exercise13 × grant or award2 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-16 | Evans John M.Director, CEO | Option exercise M | +25,000 | 1.03 | 1,072,205 | Form 4 |
| 2026-10-15 | Evans John M.Director, CEO | Option exercise M | +25,000 | 1.03 | 1,072,205 | Form 4 |
| 2026-09-24 | Ciaramella GiuseppePresident | Gift G | −123,407 | – | 130,504 | Form 4 |
| 2026-06-30 | Evans John M.Director, CEO | Option exercise M | +25,000 | 1.03 | 1,072,205 | Form 4 |
| 2026-06-29 | Evans John M.Director, CEO | Option exercise M | +18,663 | 0.67 | 1,065,868 | Form 4 |
| 2026-06-29 | Evans John M.Director, CEO | Option exercise M | +6,337 | 1.03 | 1,072,205 | Form 4 |
| 2026-06-17 | Ciaramella GiuseppePresident | Option exercise M | +6,505 | 0.67 | 224,911 | Form 4 |
| 2026-06-17 | Ciaramella GiuseppePresident | Option exercise M | +29,000 | 1.03 | 253,911 | Form 4 |
| 2026-03-31 | Ciaramella GiuseppePresident | Grant or award A | +40,000 | – | 230,216 | Form 4 |
| 2026-03-31 | Emany Sravan KumarChief Financial Officer | Grant or award A | +31,750 | – | 105,456 | Form 4 |
| 2026-03-31 | Simon AmyChief Medical Officer | Grant or award A | +31,750 | – | 109,114 | Form 4 |
| 2026-03-31 | Cavanagh Bethany JSVP, Finance and Treasurer | Grant or award A | +20,000 | – | 54,813 | Form 4 |
| 2026-03-31 | Bellon ChristineChief Legal Officer | Grant or award A | +20,000 | – | 115,667 | Form 4 |
| 2026-03-31 | Evans John M.Director, CEO | Option exercise M | +25,000 | 0.67 | 1,011,667 | Form 4 |
| 2026-03-31 | Evans John M.Director, CEO | Grant or award A | +90,000 | – | 1,076,667 | Form 4 |
| 2026-03-30 | Evans John M.Director, CEO | Option exercise M | +25,000 | 0.67 | 1,011,667 | Form 4 |
| 2026-02-24 | Ciaramella GiuseppePresident | Option exercise M | +35,000 | 17.00 | 225,216 | Form 4 |
| 2026-01-30 | Evans John M.Director, CEO | Option exercise M | +25,000 | 0.67 | 1,011,667 | Form 4 |
| 2026-01-29 | Evans John M.Director, CEO | Option exercise M | +19,336 | 0.67 | 1,006,003 | Form 4 |
| 2026-01-29 | Evans John M.Director, CEO | Option exercise M | +5,664 | 0.67 | 1,011,667 | Form 4 |
| 2025-12-31 | Simon AmyChief Medical Officer | Grant or award A | +12,500 | – | 77,364 | Form 4 |
| 2025-10-06 | Fmr LLC10% owner, Other | Gift G | −1,232,434 | – | 841,231 | Form 4 |
| 2025-10-02 | Evans John M.Director, CEO | Option exercise M | +25,000 | 0.67 | 1,011,667 | Form 4 |
| 2025-10-01 | Evans John M.Director, CEO | Option exercise M | +25,000 | 0.67 | 1,011,667 | Form 4 |
| 2025-03-31 | Evans John M.Director, CEO | Grant or award A | +77,500 | – | 1,016,159 | Form 4 |
| 2025-03-31 | Cavanagh Bethany JSVP, Finance and Treasurer | Grant or award A | +10,000 | – | 47,527 | Form 4 |
| 2025-03-31 | Ciaramella GiuseppePresident | Grant or award A | +35,000 | – | 197,650 | Form 4 |
| 2025-03-31 | Simon AmyChief Medical Officer | Grant or award A | +27,500 | – | 96,305 | Form 4 |
| 2025-03-31 | Bellon ChristineChief Legal Officer | Grant or award A | +20,000 | – | 122,968 | Form 4 |
| 2025-02-14 | Bellon ChristineChief Legal Officer | Option exercise M | +9,492 | 7.22 | 112,460 | Form 4 |
| 2025-02-14 | Bellon ChristineChief Legal Officer | Option exercise M | +508 | 7.22 | 112,968 | Form 4 |
| 2025-01-30 | Evans John M.Director, CEO | Option exercise M | +30,000 | 0.67 | 968,659 | Form 4/A |
| 2024-12-31 | Emany Sravan KumarChief Financial Officer | Grant or award A | +80,000 | – | 80,000 | Form 4 |
| 2024-12-17 | Ciaramella GiuseppePresident | Option exercise M | +53,500 | 0.67 | 162,650 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.